The detection of genetic aberrations in solid tumors with DNA Fluorescence in situ Hybridization (FISH) probe technology is a powerful means to diagnose and more efficiently treat a wide range of cancers. Abbott Molecular's Vysis FISH probes offer a comprehensive line of direct labeled DNA probes for solid tumor assessment. The probes for oncology, cytology, and pathology provide the following advantages:
- Specific high-intensity signals without amplification and detection steps
- Low background for easy analysis
- Rapid, convenient, and easy-to-use probes
- Solid tumor probes have been optimized for paraffin-embedded tissues
